UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 261

Sortiert nach

Life events and the onset of motor symptoms in Parkinson's disease

Parkinsonism & related disorders, 2023-02, Vol.107, p.105283-105283, Article 105283

2023

Volltextzugriff (PDF)

Pseudo One-And-A-Half Syndrome in a Myasthenia Gravis Patient

Neurology India, 2022-09, Vol.70 (5), p.2308

2022

Volltextzugriff (PDF)

Adult polycystic kidney disease in patients on haemodialysis in the south of Brazil

Nephrology, dialysis, transplantation, 2003-12, Vol.18 (12), p.2686-2687

2003

Volltextzugriff (PDF)

Reliability of race assessment based on the race of the ascendants: a cross-sectional study

BMC public health, 2002-01, Vol.2 (1), p.1-1, Article 1

2002

Volltextzugriff (PDF)

Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice

PloS one, 2010-01, Vol.5 (1), p.e8829-e8829

2010

Volltextzugriff (PDF)

Next-generation sequencing of HIV-1 RNA genomes: determination of error rates and minimizing artificial recombination

PloS one, 2013-09, Vol.8 (9), p.e74249-e74249

2013

Volltextzugriff (PDF)

Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study

PloS one, 2013-10, Vol.8 (10), p.e77691-e77691

2013

Volltextzugriff (PDF)

Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individuals

PloS one, 2012-05, Vol.7 (5), p.e35416-e35416

2012

Volltextzugriff (PDF)

A randomized comparative trial of continued abacavir/lamivudine plus efavirenz or replacement with efavirenz/emtricitabine/tenofovir DF in hypercholesterolemic HIV-1 infected individuals

PloS one, 2015-02, Vol.10 (2), p.e0116297

2015

Volltextzugriff (PDF)

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts

PloS one, 2016-10, Vol.11 (10), p.e0164517-e0164517

2016

Volltextzugriff (PDF)

Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer

Journal of clinical oncology, 2016-09, Vol.34 (26), p.3119-3125

2016

Volltextzugriff (PDF)

Prolonged and substantial discordance in prevalence of raltegravir-resistant HIV-1 in plasma versus PBMC samples revealed by 454 "deep" sequencing

PloS one, 2012-09, Vol.7 (9), p.e46181-e46181

2012

Volltextzugriff (PDF)

Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial

Annals of oncology, 2016-12, Vol.27 (12), p.2196-2203

2016

Volltextzugriff (PDF)

Suicide in Global Mental Health

Current psychiatry reports, 2023-06, Vol.25 (6), p.255-262

2023

Volltextzugriff (PDF)

A comparison of initial antiretroviral therapy in the Swiss HIV Cohort Study and the recommendations of the International AIDS Society-USA

PloS one, 2011-12, Vol.6 (12), p.e27903-e27903

2011

Volltextzugriff (PDF)

High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection

The Journal of infectious diseases, 2007-04, Vol.195 (7), p.951-959

2007

Volltextzugriff (PDF)

Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific region

PloS one, 2013-06, Vol.8 (6), p.e64902-e64902

2013

Volltextzugriff (PDF)

Survival outcomes and effect of early vs. deferred cART among HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort analysis

PloS one, 2011-10, Vol.6 (10), p.e26009-e26009

2011

Volltextzugriff (PDF)

Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial

Nature medicine, 2023-05, Vol.29 (5), p.1103

2023

Volltextzugriff (PDF)

Has the time come to abandon efavirenz for first-line antiretroviral therapy?

Journal of antimicrobial chemotherapy, 2014-07, Vol.69 (7), p.1742-1747

2014

Volltextzugriff (PDF)

Differential in vitro kinetics of drug resistance mutation acquisition in HIV-1 RT of subtypes B and C

PloS one, 2012-10, Vol.7 (10), p.e46622

2012

Volltextzugriff (PDF)

Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain

Retrovirology, 2017-10, Vol.14 (1), p.47-47, Article 47

2017

Volltextzugriff (PDF)

Long lasting control of viral rebound with a new drug ABX464 targeting Rev - mediated viral RNA biogenesis

Retrovirology, 2015-04, Vol.12 (1), p.30-30, Article 30

2015

Volltextzugriff (PDF)

Association between mental disorders and adherence to antiretroviral treatment in health facilities in two Mozambican provinces in 2018: a cross-sectional study

BMC psychiatry, 2023-04, Vol.23 (1), p.274-274, Article 274

2023

Volltextzugriff (PDF)

1 – 25 von 261

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(242)
Mit Volltextzugriff
(241)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Life events and the onset of motor symptoms in Parkinson's disease

Pseudo One-And-A-Half Syndrome in a Myasthenia Gravis Patient

Adult polycystic kidney disease in patients on haemodialysis in the south of Brazil

Reliability of race assessment based on the race of the ascendants: a cross-sectional study

Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice

Next-generation sequencing of HIV-1 RNA genomes: determination of error rates and minimizing artificial recombination

Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study

Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individuals

A randomized comparative trial of continued abacavir/lamivudine plus efavirenz or replacement with efavirenz/emtricitabine/tenofovir DF in hypercholesterolemic HIV-1 infected individuals

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts

Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer

Prolonged and substantial discordance in prevalence of raltegravir-resistant HIV-1 in plasma versus PBMC samples revealed by 454 "deep" sequencing

Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial

Suicide in Global Mental Health

A comparison of initial antiretroviral therapy in the Swiss HIV Cohort Study and the recommendations of the International AIDS Society-USA

High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection

Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III Trial

Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific region

Survival outcomes and effect of early vs. deferred cART among HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort analysis

Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial

Has the time come to abandon efavirenz for first-line antiretroviral therapy?

Differential in vitro kinetics of drug resistance mutation acquisition in HIV-1 RT of subtypes B and C

Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain

Long lasting control of viral rebound with a new drug ABX464 targeting Rev - mediated viral RNA biogenesis

Association between mental disorders and adherence to antiretroviral treatment in health facilities in two Mozambican provinces in 2018: a cross-sectional study

Suchergebnisse filtern